(Q64992876)

English

A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice.

scientific article published on 24 May 2019

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice. (English)

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Hepatitis C virus

object named as

Hepatitis C Virus

1 reference

based on heuristic

inferred from title

author name string

Makutiro Ghislain Masavuli

1

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Danushka K Wijesundara

2

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Alexander Underwood

3

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Dale Christiansen

4

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Linda Earnest-Silveira

5

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Rowena Bull

6

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Joseph Torresi

7

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Eric J Gowans

8

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Branka Grubor-Bauk

9

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

publication date

24 May 2019

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Frontiers in Immunology

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

10

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

1145

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

copyright license

Creative Commons Attribution 4.0 International

24 May 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6543710/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of a successful immune response against hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What are oligomerization domains good for?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies, viruses and vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-genotype immunity to hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addressing the mysteries of perforin function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assembly of a functional HCV glycoprotein heterodimer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Cytotoxic T-Lymphocyte Epitope Variant Cross-Recognition and Functional Avidity Are Associated with Hepatitis C Virus Clearance

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HCV selection and HVR1 evolution in a chimpanzee chronically infected with HCV-1 over 12 years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The oligomerization domain of C4-binding protein (C4bp) acts as an adjuvant, and the fusion protein comprised of the 19-kilodalton merozoite surface protein 1 fused with the murine C4bp domain protects mice against malaria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccines: ready for prime time?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of hepatitis C virus vaccines: challenges and progress.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterologous prime-boost vaccination.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccine manufacture: scale and quality

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An effective HIV vaccine: A combination of humoral and cellular immunity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress in the development of preventive and therapeutic vaccines for hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A genetically humanized mouse model for hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection from endogenous perforin: glycans and the C terminus regulate exocytic trafficking in cytotoxic lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intradermal naked plasmid DNA immunization: mechanisms of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaques

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Containing "The Great Houdini" of viruses: combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ins and outs of hepatitis C virus entry and assembly

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccines: roles against diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curing chronic hepatitis C--the arc of a medical triumph

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C drugs not reaching poor

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HCV E2 core structures and mAbs: something is still missing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of hepatitis C virus entry on viral tropism

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C reinfection after sustained virological response

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent manner

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Understanding the Determinants of BnAb Induction in Acute HCV Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/31178869

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FIMMU.2019.01145

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6543710

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64992876&oldid=1885544724"